stockrow
Saturday 7 November 2026
Export YDES’s income statement to Excel — free account
YD Bio Limited
YDES Healthcare Biotechnology
6.01
1.17
−16.30%
Follow YDES
Alert me
YD Bio Limited (YDES) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CAPR Capricor Therapeutics, Inc. compare | n/m |
| NGNE Neurogene Inc. compare | n/m |
| FTH Faeth Therapeutics, Inc. compare | n/m |
| ENTX Entera Bio Ltd. compare | n/m |
| OVID Ovid Therapeutics compare | n/m |
| CLYM Climb Bio, Inc. compare | n/m |
| PBYI Puma Biotechnology, Inc. compare | 15.3× |
| YDES YD Bio Limited | — |
| SLBT SL SCIENCE HLDG compare | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)